Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (602)	8/14/2002 7:01:05 AM
From: Icebrg	Read Replies (2) \| Respond to of 2240

>>In addition, during the second quarter of 2002, Medarex made a determination to delay indefinitely the planned construction of a large-scale manufacturing facility at the Bloomsbury location. As a result of this decision, Medarex recorded a charge of $11.3 million, representing the write-off of design, engineering and other pre-construction costs relating to the Bloomsbury facility. To address its anticipated late-stage clinical and commercial manufacturing requirements, Medarex plans to pursue supply agreements with third party manufacturers with available capacity to meet internal Medarex production timetables.>> This was very surprising. Third party manufacturing capacity is supposed to be relatively scarce. They will have some explaining to do at the CC. Ice